Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome

Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Chest (Impact Factor: 7.13). 04/2006; 129(3):632-7. DOI: 10.1378/chest.129.3.632
Source: PubMed

ABSTRACT Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for atherosclerosis. CD40-CD40 ligand interaction promotes several proinflammatory mediators and plays a pivotal role in the various stages of atherosclerotic diseases. The present study examines whether CD40 ligation contributes to outcomes in patients with OSAS.
The study population comprised OSAS patients with an apnea hypopnea index (AHI) > or = 30 (n = 35) and control subjects (AHI < 5; n = 16). We measured serum levels of soluble CD40 ligand (sCD40L), tumor necrosis factor (TNF)-alpha, and hypersensitive C-reactive protein (hsCRP) before and after nasal continuous positive airway pressure (nCPAP) therapy for 3 months.
Baseline levels of sCD40L were significantly higher in patients with OSAS (6.93 +/- 4.64 ng/mL) [mean +/- SD] than in control subjects (3.43 +/- 2.11 ng/mL, p < 0.01). Baseline levels of sCD40L positively correlated with TNF-alpha but not with hsCRP. The elevation of sCD40L was improved for 1 night after nCPAP therapy (3.83 +/- 2.78 ng/mL, p < 0.001). Even though patients with severe OSAS did not receive any other medication to control atherosclerotic risk factors for 3 months, nCPAP was continued to reduce the levels of sCD40L.
The present study suggested that sCD40L is a key factor that links OSAS and atherosclerotic progression.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to evaluate the risk of atheromatosis in patients with obstructive sleep apnea (OSA), as based on the concentration of the pro-atherogenic soluble CD40L ligand (sCD40L) in relation to the level of uric acid. The serum levels of sCD40L and uric acid were measured in 79 OSA patients (mean apnea/hypopnea index - AHI 34.4 ± 20.9) and in 40 healthy controls. We found that sCD40L was higher in the OSA patients with hyperuricemia than that in the patients with uric acid in the normal range (sCD40L: 9.0 ng/ml vs. 8.0 ng/ml, respectively, p < 0.05). There was a positive association of sCD40L with AHI (p = 0.01) and a negative one with the mean minimal nocturnal SaO2 (p < 0.05). Uric acid correlated negatively with the mean and minimal SaO2 and positively with the oxygen desaturation index (p < 0.05). OSA patients with hyperuricemia also had a higher prevalence of hypertension and ischemic heart disease. We conclude that OSA patients with increased uric acid concentration have increased risk of atheromatosis, as indicated by a higher level of soluble pro-atherogenic ligand CD40, and a higher prevalence of cardiovascular adverse events.
    Advances in Experimental Medicine and Biology 10/2014; DOI:10.1007/5584_2014_44 · 2.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Immune activation modulates sleep by influencing brain neurons involved in the regulation and maintenance of sleep-wake cycles and arousal states. The precise mechanisms by which this occurs are not completely established, but seem to follow from direct influences of immune-derived mediators, such as cytokines, on sleep/wake neurons (Opp 2005), and/or via activation of peripheral viscerosensory neurons driving brain neural circuits that modulate arousal states in response to internal and external challenges. In this chapter we will review the organization of visceral sensory pathways that carry immune-related information to the brain, and recent findings regarding the brain neurocircuitry connecting immune-brain interfaces with arousal network nuclei that influence sleep-wake states.
    12/2006: pages 119-131;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: During acute or chronic infection and inflammation complex changes in a variety of physiological systems occur. In addition to changes in temperature or the induction of fever also behavioral changes like tiredness, flu-like symptoms and impaired concentration are common. During the last 20 to 30 years there is rapidly growing interest and also knowledge about the underlying mechanisms: One of the first important findings was the observation, that the hypothalamo-pituitary-adrenal (HPA) system is stimulated following the peripheral administration of interleukin-1 (IL-1) (Besedovsky, del Rey, Sorkin, and Dinarello 1986). After this basic finding in psychoneuroimmunological research further studies focused on the inflammatory cytokines such as IL-1 as major components in the interaction of peripheral immune function and central nervous system (CNS): These peptides belong to the huge number of cytokines which are involved in this brain-immune interaction (see Hopkins and Rothwell 1995; Rothwell and Hopkins 1995). In human research mainly cytokines of the cytokine families of interleukins, interferons (IFN), or the tumor necrosis factor (TNF) family have been investigated.
    12/2006: pages 227-231;